| Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587) |
|---|
| 07/31/2007 | US7250424 Fab I inhibitors |
| 07/31/2007 | US7250421 Diketo acids with nucleobase scaffolds: anti-HIV replication inhibitors targeted at HIV integrase |
| 07/31/2007 | US7250418 Corticotropin releasing factor antagonist; antiinflammatory agents; drug abuse; analgesics; antihistamines; skin disorders; neurodegenerative disease; eating disorders;eating disorders; antiepileptic agents; cardiovascular disorders |
| 07/31/2007 | US7250414 Antihistamines; bronchodilator agents; respiratory system disorders; 2-{(S)-1-[4-(4-aminophenyl)butyl]pyrrolidin-3-yl}-2,2-diphenylacetamide; chemical synthesis; Bioassay of testing the compound on the biological sample |
| 07/31/2007 | US7250410 Cyclic nucleotide phosphodiesterase inhibitors, preparation and uses thereof |
| 07/31/2007 | US7250063 Diaminopyrazole derivatives and their use for oxidation dyeing of keratinous fibres |
| 07/31/2007 | CA2275306C Novel tetrahydrobenzindolone derivatives |
| 07/31/2007 | CA2175212C Heteroarylpiperidines, pyrrolidines and piperazines and their use as antipsychotics and analgetics |
| 07/31/2007 | CA2121253C Heteroarylpiperidines, pyrrolidines and piperazines and their use as antipsychotics and analgetics |
| 07/26/2007 | WO2007084875A2 Spiro compounds and methods of use |
| 07/26/2007 | WO2007084455A1 Hydantoin compounds for the treatment of inflammatory disorders |
| 07/26/2007 | WO2007084451A1 Hydantoin derivatives for the treatment of inflammatory disorders |
| 07/26/2007 | WO2007084413A2 Methods for treating hepatitis c |
| 07/26/2007 | WO2007084135A2 Inhibitors of checkpoint kinases |
| 07/26/2007 | WO2007083732A1 Optical recording medium and azo metal chelate compound |
| 07/26/2007 | WO2007083692A1 Aminopyridine derivative and plant disease control agent for agricultural or horticultural use |
| 07/26/2007 | WO2007083207A1 Substituted imidazoles and their use as pesticides |
| 07/26/2007 | WO2007082880A1 Pyridine and pyrimidine derivatives as inhibitors of histone deacetylase |
| 07/26/2007 | WO2007082874A1 Pyridine and pyrimidine derivatives as inhibitors of histone deacetylase |
| 07/26/2007 | WO2007082805A1 Cis-4, 5-biaryl-2-heterocyclic-imidazolines as mdm2 inhibitors |
| 07/26/2007 | WO2007082666A1 Acylaminoimidazoles |
| 07/26/2007 | WO2007082434A1 Quinazoline derivatives,preparation methods and uses thereof |
| 07/26/2007 | WO2007062999A3 1,5-substituted indol-2-yl amide derivatives |
| 07/26/2007 | WO2007061360A3 Novel 3-bicyclocarbonylaminopyridine-2-carboxamides or 3-bicyclocarbonylaminopyrazine-2-carboxamides |
| 07/26/2007 | WO2007022501A3 Useful indole compounds |
| 07/26/2007 | WO2006127588A3 Modulators of atp-binding cassette transporters |
| 07/26/2007 | US20070173647 Method for the preparation of dicarboxylic imides |
| 07/26/2007 | US20070173527 Histone deacetylase inhibitors |
| 07/26/2007 | US20070173524 N-[2-(Indol-3-yl)ethyl]-S-methyl-dithiocarbamate; N-[2-(benzo[b]thiophen-3-yl)ethyl]-S-methyl-dithiocarbamate; N-[2-(indol-3-yl)ethyl]-S[(naphth-2-yl)methyl]-dithiocarbamate; anticarcinogenic agents; free of brassinin |
| 07/26/2007 | US20070173516 Pyrazine kinase inhibitors |
| 07/26/2007 | US20070173513 Imidazole compounds |
| 07/26/2007 | US20070173512 Imidazole compounds |
| 07/26/2007 | US20070173510 Imidazole compounds |
| 07/26/2007 | US20070173509 Imidazole compounds |
| 07/26/2007 | US20070173507 Dairyl-substituted five-membered heterocycle derivative |
| 07/26/2007 | US20070173503 Novel 4-benzimidazol-2-ylpyridazin-3-one derivatives |
| 07/26/2007 | US20070173494 Diaza heterocyclic sulfonamide derivatives and their uses |
| 07/26/2007 | US20070173491 Substituted lactams as inhibitors of Abeta protein production |
| 07/26/2007 | US20070173489 antagonists of the interaction between the plasma protein von Willebrand factor (vWF) and the blood platelet receptor glycoprotein Ib-IX-V complex, exhibit anticoagulant effect and are suitable for the therapy and prophylaxis of cardiovascular disorders |
| 07/26/2007 | US20070173486 e.g. 3-(2,4,4'-trichlorobenzhydryloxy)-N-(tert-butyl)azetidine-1-carboxamide; cannabinoid receptor antagonist; antidiabetic agent; antidepressant; eating disorders, obesity, nicotine addiction, neuropathy, cognitive disorders, attention deficit disorder, stress, epilepsy, dementia, distonia, Alzheimer's |
| 07/26/2007 | US20070172826 Electrochemically active ligand for sequence-specific detection of double-stranded nucleic acid molecule |
| 07/26/2007 | US20070172421 Substituted pyrrolidine-2-ones |
| 07/26/2007 | CA2637565A1 Cannibinoid receptor modulators |
| 07/26/2007 | CA2637385A1 Compounds for the treatment of inflammatory disorders |
| 07/26/2007 | CA2637198A1 Hydantoin compounds for the treatment of inflammatory disorders |
| 07/26/2007 | CA2637196A1 Hydantoin derivatives for the treatment of inflammatory disorders |
| 07/26/2007 | CA2636916A1 Methods for treating hepatitis c |
| 07/26/2007 | CA2636905A1 Methods for treating hepatitis c |
| 07/26/2007 | CA2636824A1 Cis-4,5-biaryl-2-heterocyclic-imidazolines as mdm2 inhibitors |
| 07/26/2007 | CA2633100A1 Pyridine and pyrimidine derivatives as inhibitors of histone deacetylase |
| 07/26/2007 | CA2631504A1 Novel cyclic urea derivatives, preparation thereof and pharmaceutical use thereof as kinase inhibitors |
| 07/26/2007 | CA2630717A1 Pyridine and pyrimidine derivatives as inhibitors of histone deacetylase |
| 07/26/2007 | CA2600914A1 Inhibitors of checkpoint kinases |
| 07/25/2007 | EP1810970A1 Therapeutic piperazine compounds |
| 07/25/2007 | EP1809624A1 Pyrimidine sulphonamide derivatives as chemokine receptor modulators |
| 07/25/2007 | EP1809623A1 Process for the preparation of irbesartan hydrochloride |
| 07/25/2007 | EP1809622A1 Inhibitors of the interaction between mdm2 and p53 |
| 07/25/2007 | EP1809610A1 Production method of pyrimidine compounds |
| 07/25/2007 | EP1809607A1 Sulfonyl benzimidazole derivatives |
| 07/25/2007 | EP1809603A1 Nitrobenzindoles and their use in cancer therapy |
| 07/25/2007 | EP1809290A2 Pyrimidine derivatives as ion channel modulators and methods of use |
| 07/25/2007 | EP1658272B1 Novel gamma-secretase inhibitors |
| 07/25/2007 | EP1558581A4 Triazolone and triazolethione derivatives |
| 07/25/2007 | EP1389190B1 Diamide invertebrate pest control agents containing a non-aromatic heterocyclic ring |
| 07/25/2007 | EP1322710B9 Modified carbocyanine dyes and their conjugates |
| 07/25/2007 | EP1177187B1 Di-aryl acid derivatives as ppar receptor ligands |
| 07/25/2007 | CN1328261C Uracil compounds and their use |
| 07/25/2007 | CN1328247C N-biphenylmethyl aminocycloalkanecarboxamide derivatives with a substiituent on the methyl useful as bradykinin antagonists |
| 07/25/2007 | CN101006083A Dpp-iv inhibitors |
| 07/25/2007 | CN101006082A Histamine H3 receptor agents, preparation and therapeutic uses |
| 07/25/2007 | CN101006080A N CC-1065 analogues for use against cancers |
| 07/25/2007 | CN101006079A 嘧啶衍生物 Pyrimidine derivatives |
| 07/25/2007 | CN101006078A Gonadotropin releasing hormone receptor antagonists |
| 07/25/2007 | CN101006055A 3-substituted-5- and 6-aminoalkyl indole-2-carboxylic acid amides and related analogs as inhibitors of casein kinase iepsilon |
| 07/25/2007 | CN101005841A 雄激素受体调节剂 Androgen receptor modulators |
| 07/25/2007 | CN101003532A Method for producing antifungal drug in triazole class |
| 07/25/2007 | CN101003515A 4-anilino quinazoline derivatives as antiproliferative agents |
| 07/24/2007 | US7247735 Having a benzene ring 1,3,5-trisubstituted with 2-6 conjugated thiophene, furan or pyrrole rings, e.g., 1,3,5-Tris[-(5'''-ethyl)-2,2':5',2'':5'',2'''-quartthiophenyl]benzene |
| 07/24/2007 | US7247734 In which the 3-phenyl group is 2,4-dihydroxy-substituted, e.g., 4-[5-bromo-4-(4-methoxy-phenyl)-1H-pyrazol-3-yl]-6-chloro-benzene-1,3-diol; heat shock protein 90 inhibitors |
| 07/24/2007 | US7247637 e.g., N-(3,5-diamino-6-chloropyrazine-2-carbonyl)-N'-(4-{4-[3-(1H-tetrazol-5-yl)propoxy]phenyl}butyl)guanidine hydrochloride; used to hydrate mucosal surfaces; are absorbed less rapidly, thus have a prolonged pharmacodynamic half-life |
| 07/24/2007 | US7247635 Pyrazole derivative |
| 07/24/2007 | US7247633 Pyrimidine compounds and their use |
| 07/24/2007 | US7247628 Cannabinoid receptor ligands and uses thereof |
| 07/24/2007 | US7247627 non-hygroscopic, crystalline anhydrous maleate salt of 5-[(Z)-(5-fluoro-2-oxo-1,2-dihydro-3H-indol-3-ylidene) methyl]-N-[(2S)-2-hydroxy-3-morpholin-4-ylpropyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide |
| 07/24/2007 | US7247624 e.g. 5-Benzyloxy-2-(4-benzyloxy-phenyl)-3-methyl-1H-indole or salts for treating colon cancer |
| 07/19/2007 | WO2007081995A2 Urotensin ii receptor antagonists |
| 07/19/2007 | WO2007081571A2 Cetp inhibitors |
| 07/19/2007 | WO2007081560A2 Amino acid derivatives of indolinone based protein kinase inhibitors |
| 07/19/2007 | WO2007080947A1 Diketooxime ester compound and use thereof |
| 07/19/2007 | WO2007080720A1 Pyridazine compound and use thereof |
| 07/19/2007 | WO2007080401A1 Triazoloanilinopyrimidine derivatives for use as antiviral agents |
| 07/19/2007 | WO2007080382A1 Morpholino pyrimidine derivatives and their use in therapy |
| 07/19/2007 | WO2007079653A1 OPTICALLY PURE α-SUBSTITUTED 2-METHYL-5-NITROIMIDAZOLE-1-ETHANOL DERIVATIVES |
| 07/19/2007 | WO2007054453A3 Carbocyclic fused cyclic amines as inhibitors of the coagulation factor xa |
| 07/19/2007 | WO2007051081B1 Methods and compounds for preparing cc-1065 analogs |
| 07/19/2007 | US20070167655 Method for the production of tetrahydrogeranylacetone |
| 07/19/2007 | US20070167621 Substituted pyrimidinones |
| 07/19/2007 | US20070167507 4-Carbox pyrazole derivatives useful as anti-viral agents |
| 07/19/2007 | US20070167505 Substituted benzimidazoles and their use for inducing apoptosis |
| 07/19/2007 | US20070167499 Biaryl linked hydroxamates: preparation and pharmaceutical applications |